Latest News
Bipartisan bill in Congress would require drug makers to justify, limit price hikes
(By Ed Silverman for STAT)
In response to the intensifying outrage over the cost of medicines, a bipartisan group of lawmakers Thursday introduced a bill1 that would require drug makers to justify their pricing and provide a breakdown of their costs before raising prices on certain products by more than 10 percent. Continue reading article here…
This posting is presented for informational purposes only and does not represent legal or financial guidance. Any opinions or interpretations presented are either those of the original author or, in the case of articles authored by the AMAC Foundation, are the opinions of AMAC Foundation staff, originally trained and accredited by the National Social Security Association (NSSA) and certified via the AMAC Foundation. Any links included in the article are valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the links’ validity. NSSA and the AMAC Foundation and its staff are not affiliated with or endorsed by the Social Security Administration or any other governmental entity. To submit a question, visit our website (https://amacfoundation.org/services/) or email us at ssadvisor@amacfoundation.org. Because we are a non-profit organization, there is no charge for these services.